Exousia Bio (LMMY) Receivables (2023 - 2024)
Exousia Bio (LMMY) posted Receivables of $16689.0 for Q4 2024, up 3.55% sequentially from $16117.0 in Q3 2024, and up 330.68% YoY from $3875.0 in Q4 2023.
Powered by 
Analysis
Exousia Bio (LMMY) Receivables (2023 - 2024) Analysis & Trends
Exousia Bio (LMMY) has 2 years of Receivables data on file, last reported at $16689.0 in Q4 2024.
- Quarterly Receivables rose 330.68% year-over-year to $16689.0 in Q4 2024, while the trailing twelve-month figure through Nov 2024 was $16689.0 (up 330.68% YoY) and the FY2024 annual result came in at $11936.0, changed N/A from the prior year.
- Receivables rose to $16689.0 in Q4 2024 per LMMY's latest filing, from $16117.0 in the prior quarter.
- The five-year high for Receivables was $16689.0 in Q4 2024, with the low at $3875.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | New Oriental Education & Technology | 94.30 Bn | 91.56 Bn | 812.22 Mn | 44.73 Mn |
| 2 | Laureate Education | 5.01 Bn | 4.85 Bn | 237.67 Mn | 287.81 Mn |
| 3 | Graham Holdings | 4.80 Bn | 3.55 Bn | 777.03 Mn | 529.89 Mn |
| 4 | Covista | 4.49 Bn | 4.08 Bn | 284.63 Mn | 169.56 Mn |
| 5 | Grand Canyon Education | 3.98 Bn | 3.70 Bn | 204.08 Mn | 38.91 Mn |
| 6 | Stride | 3.66 Bn | 2.70 Bn | 217.28 Mn | 689.14 Mn |
| 7 | McGraw Hill | 2.54 Bn | 2.35 Bn | 439.20 Mn | 377.88 Mn |
| 8 | Perdoceo Education | 2.08 Bn | 772.00 Mn | 162.46 Mn | 47.07 Mn |
| 9 | TAL Education | 1.93 Bn | -755.67 Mn | 227.32 Mn | - |
| 10 | Exousia Bio | 368,824.87 | 368,824.87 | -62,108.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Nov 30, 2024 | 16,689.00 |
| Aug 31, 2024 | 16,117.00 |
| May 31, 2024 | 11,936.00 |
| Feb 29, 2024 | 7,750.00 |
| Nov 30, 2023 | 3,875.00 |